Fenofibrate Nanocrystalize
SPE2D220R0073 · DEPT OF DEFENSE
A PHARMACEUTICAL PREPARATION MANUFACTURING solicitation, with responses due 2020-10-23. AwardCast estimates what this specific solicitation will close for, before you bid.
SPE2D220R0073
solicitation
325412
NAICS
6505
PSC
Not set aside
set-aside
2020-10-23
responses due
What's being bought
Option Year 1 P00001 SPE2D2-21-D-0131 to invoke option period of April 05, 2022 through April 04, 2023. Amendment 0001 is issued to extend the closing date until October 23, 2020 at 3:00 PM EDT. Solicitation for Fenofibrate Nanocrystalize Tablets SPE2D2-20-R-0073.
Comparable recent awards in PHARMACEUTICAL PREPARATION MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| SR-SERVICES GMBH | $25K | 2 | 2024-09-30 |
| AMERICAN REGENT INC | $926 | n/a | 2024-09-30 |
| PFIZER INC | $2.2M | 4 | 2024-09-30 |
| ADVANCED ACCELERATOR APPLICATIONS USA INC | $1.9M | n/a | 2024-09-30 |
| FRESENIUS KABI USA, LLC | $5.4M | 4 | 2024-09-30 |
Explore the market
Comparable awards ran from $926 to $5.4M. Get AwardCast's forecast for THIS solicitation's closing price.
AwardCast forecasts what U.S. federal contracts close for, before you bid. Built on USASpending and SAM.gov. Not affiliated with the U.S. government. Technology by Chosing DEPT.